1252 related articles for article (PubMed ID: 30355953)
21. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
23. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
Qu X; Liu T; Song K; Li X; Ge D
PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200
[TBL] [Abstract][Full Text] [Related]
25. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
26. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
[TBL] [Abstract][Full Text] [Related]
27. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
28. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
29. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
[TBL] [Abstract][Full Text] [Related]
30. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.
Shoji E; Woltjen K; Sakurai H
Methods Mol Biol; 2016; 1353():89-99. PubMed ID: 25971915
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
32. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
33. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
[TBL] [Abstract][Full Text] [Related]
34. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
[TBL] [Abstract][Full Text] [Related]
35. Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.
Trokovic R; Weltner J; Nishimura K; Ohtaka M; Nakanishi M; Salomaa V; Jalanko A; Otonkoski T; Kyttälä A
Stem Cells Transl Med; 2014 Dec; 3(12):1402-9. PubMed ID: 25355732
[TBL] [Abstract][Full Text] [Related]
36. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
Jin ZB; Okamoto S; Xiang P; Takahashi M
Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
[TBL] [Abstract][Full Text] [Related]
37. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
38. iPSCs-based generation of vascular cells: reprogramming approaches and applications.
Klein D
Cell Mol Life Sci; 2018 Apr; 75(8):1411-1433. PubMed ID: 29243171
[TBL] [Abstract][Full Text] [Related]
39. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
40. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]